Immunoelectron microscopy showed elevated cell surface expression of MK in PMN and monocytes during hypoxia. However, only HUVEC released significant amounts of soluble MK during hypoxia compared with normoxia (301 Ϯ 81 pg/ml vs. 158 Ϯ 45 pg/ml; P Ͻ 0.05). Exogenous MK induced neovascularization in a chorioallantoic membrane (CAM) assay compared with negative control as measured by counting the number of branching points per visual field (1,074 Ϯ 54 vs. 211 Ϯ 70; P Ͻ 0.05). In a hind limb ischemia model, the angiogenic response was almost completely absent in MK-deficient mice, whereas control animals showed a profound angiogenic response measured as proliferating endothelial cells per visual field (45 Ϯ 30 vs. 169 Ϯ 34; P Ͻ 0.01). These unanticipated results identified endothelial cells as the source of soluble MK in the vascular system during hypoxia and defined MK as a pivotal player of angiogenesis during ischemia in nonmalignant tissue. vascular biology; ischemia; endothelial cells; leukocytes
THE 13-KDA CYTOKINE MIDKINE (MK) belongs to a family of heparinbinding growth factors, which consists of one additional member named pleiotrophin sharing ϳ50% amino acid sequence identity with human MK (23) . It has been shown that hypoxia induced MK expression in different cancer cell lines (32) . In human lung cancer cells, MK expression was found to be induced by binding of the hypoxia inducible factor 1-␣ (HIF1-␣) to a hypoxia response element in the MK promoter (32) . In contrast with cancer cells, MK expression is rarely expressed in healthy tissues of the adult organism (23) .
Several studies have linked MK to tumor growth, and increased serum levels of MK were detected in patients suffering from various types of cancer (13, 24) . Accordingly, different tumor entities showed increased MK mRNA and protein expression positively correlating with tumor size and tumor malignancy (30) . Overexpression of MK in transfected tumor cell lines led to increased tumor growth after subcutaneous injection into nude mice (6, 22, 36) . In contrast, cancer cell lines overexpressing MK did not show increased proliferation in vitro compared with control cells, suggesting that MK did not directly induce proliferation of tumor cells in the in vivo model used.
However, the tumor growth promoting activity of MK has been found to be due to its ability to promote tumor angiogenesis. Enhanced tumor growth after subcutaneous injection of MK into nude mice as mentioned above was associated with increased microvessel density indicating enhanced proliferation of endothelial cells within the tumor (6, 22) . High MK protein expression correlated positively with enhanced microvessel density (30) . Interestingly, high MK expression was localized in tumor endothelial cells of human neural tumor tissues, suggesting that endothelial cells also can represent the source of MK during tumor angiogenesis (20) . In addition, conditioned media of cancer cells overexpressing MK have been shown to induce angiogenesis by promoting proliferation of endothelial cells in vitro (22, 36) . Antisense oligonucleotides against MK inhibited growth of endothelial cells in vitro and tumor-induced angiogenesis in a chorioallantoic membrane (CAM) assay and tumor vascularization in vivo (7) .
Moreover, there is evidence that MK is not only involved in tumor angiogenesis but also critical for hypoxia-induced angiogenesis during ischemia of normal tissue in the adult organism. Myocardial injury after ischemia/reperfusion upon transient occlusion of the left coronary artery in mice led to increased MK protein expression in the peri-infarct area compared with noninfarcted myocardium (12) . Furthermore, injection of an adenoviral vector encoding MK or direct application of recombinant MK into the heart after myocardial infarction caused by ligation of the left anterior descending artery in rats showed enhanced neovascularization in the peri-infarct area, suggesting that MK may induce angiogenesis in this model (11, 38) . Thus there is a growing body of evidence for a functional role of MK for induction of angiogenesis in the adult organism, but the source of soluble MK in the vascular system of nonmalignant tissue during hypoxia was still undefined.
Different cell types contribute to the orchestration of the angiogenic response under physiological and pathophysiological conditions in the adult organism. Besides resident tissue cells and endothelial cells, inflammatory cells including polymorphonuclear neutrophils (PMN) and monocytes/macrophages also have been found to play an important role during angiogenesis (27, 34) . Macrophages are known for their plasticity. Depending on the surrounding microenvironment macrophages can differentiate into different phenotypes. Although M1-macrophages are tumoricidal and elicit tissue destructive reactions, "M2-like" macrophages promote tissue repair, remodeling, tumor growth, and angiogenesis (2, 19) . Hypoxic conditions alter the gene expression profile of macrophages toward an M2-phenotype, which subsequently contribute to formation of new blood vessels by secreting different proangiogenic factors (25) . Similar to macrophages, PMN can release proinflammatory and/or angiogenic molecules depending on the signals they receive (28, 41) . Chemokines of the CXC family containing an "ELR"-motif, a glutamic acid-leucinearginine sequence proximal to CXC, are potent promoters of an angiogenic response (16) . Moreover, chemokines like CXCL1 can mediate angiogenesis by inducing the release of the proangiogenic factor VEGF-A from PMN (33) .
In the present study, we analyzed the effect of hypoxia on protein expression of MK in PMN, monocytes, and endothelial cells. Furthermore, we investigated the angiogenic potential of exogenous MK and studied the biological relevance of endogenous MK for induction of angiogenesis under ischemic conditions in nonmalignant tissue of the adult organism in vivo using a hind limb ischemia model in wild-type (WT) mice and MK-deficient animals.
MATERIALS AND METHODS
Mice. Mice carrying the MK tm1Tmu allele (referred to as MK Ϫ/Ϫ ) were generated as described elsewhere (26) . MK Ϫ/Ϫ and WT control mice were maintained on C57Bl/6J background. Animal experiments were conducted according to the Animal Welfare Act and institutionally approved.
Reagents and antibodies. Human VEGF was delivered by Biomol (Hamburg, Germany) and human MK by PeproTech (Rocky Hill, NJ). The polyclonal rabbit anti-MK Ab, the goat anti-␤-actin Ab, and the polyclonal goat anti-Ki67 were purchased from Santa Cruz (Santa Cruz, CA). The polyclonal goat anti-MK Ab was obtained from R&D Systems (Minneapolis, MN). The monoclonal anti-58K Golgi protein Ab and the polyclonal rabbit anti-␣ smooth muscle actin (␣SM-actin) Ab were ordered from Abcam (Cambridge, UK). The monoclonal rat anti-CD31 Ab was purchased from Linaris (Mannheim, Germany), and the BS-1 lectin Ab from Vector (Burlingame, CA). The peroxidase-conjugated goat anti-mouse IgG Ab and goat anti-rabbit IgG Ab were ordered from Sigma (Deisenhofen, Germany). The peroxidase-conjugated rabbit anti-goat IgG Ab was obtained from Calbiochem (Darmstadt, Germany). The Alexa 546-conjugated donkey anti-goat IgG Ab, Alexa 568-conjugated goat anti-rabbit IgG Ab, Alexa 488 goat antimouse IgG Ab, and Alexa 488 chicken anti-rabbit Ab were delivered by Molecular Probes (Eugene, OR). Gold particle conjugated secondary antibodies were purchased from Amersham (Braunschweig, Germany).
Isolation of human PMN. Human blood was drawn from healthy adult volunteers and anticoagulated with sodium citrate (0.3%). Blood collection was conducted according to the Helsinki Declaration and was approved by the Institutional Ethics Committee of the Ludwigs Maximilians University. All subjects gave written informed consent. Spontaneous erythrocyte sedimentation was performed in the presence of 40% (vol/vol) of autologous plasma. The leukocyte-rich plasma was layered onto a discontinuous (3 ml of 55% on 4 ml of 74%) isotonic Percoll gradient as described (42) and centrifuged at 600 g for 20 min. The PMN-containing lower band was collected and washed in PBS, resuspended in RPMI 1640 Medium with 20 mM HEPES and stable glutamine, and brought to a final concentration of ϳ5 ϫ 10 6 PMN/ml. PMN purity as analyzed by microscopy using Haemacolor staining (Merck, Darmstadt, Germany) was Ͼ99%. PMN viability as evaluated by Trypan blue exclusion test was Ͼ99%.
Isolation of human monocytes. Human monocytes were isolated from freshly drawn blood anticoagulated with citrate (0.3%) of healthy adult volunteers as described above. Blood was diluted 2.5:1 (vol/vol) in PBS, loaded on Ficoll-Paque, and centrifuged at 400 g for 20 min. The mononuclear fraction in the plasma Ficoll interphase was collected and washed in PBS. Human monocytes were finally isolated by negative selection using the Monocyte Isolation Kit II (Miltenyi Biotec, Bergisch Gladbach, Germany). Magnetic labeling and separation were conducted according to the manufacturer's instructions. Viability and purity were evaluated as described above.
Isolation of human umbilical vein endothelial cells. The central vein of human umbilical cords was flushed with PBS at 37°C supplemented with penicillin (50 units/ml) and streptomycin (50 g/ml) and filled with collagenase solution in PBS (0.1%). After an incubation period of 12 min at 37°C, human umbilical vein endothelial cells (HUVEC) were flushed out and collected in RPMI 1640 medium with 1% FCS. After HUVEC were washed twice with PBS, HUVEC were suspended in RPMI 1640 medium supplemented with 5% FCS and 50% endothelial cell growth medium. HUVEC were placed in 25 cm 2 tissue culture flasks (BD Biosciences, Franklin Lakes, NJ) and cultivated in 5% CO 2 at 37°C. In all experiments, only confluent primary endothelial cells in the first passage were used.
SDS page and immunoblotting. Samples were lysed in 1 ϫ Laemmli-buffer of 200 mM Tris·HCl (pH 7.5) containing 2% SDS, 6% 2-mercaptoethanol, 10% glycerol, and 0.01% bromphenol blue and incubated for 5 min at 95°C. Total cell lysates (2 ϫ 10 6 cells/sample) were subjected on SDS page on gels containing 14% acrylamide. After cell lysates were blocked with 3% BSA in Tris-buffered salineTween for 1 h, Western blot was performed using the primary rabbit anti-MK Ab (Santa Cruz) in a final dilution of 1:400 at 4°C overnight. After cell lysates were washed four times with Tris-buffered salineTween, the secondary peroxidase-conjugated goat anti-rabbit IgG Ab (Sigma, Deisenhofen, Germany) was applied in a final dilution of 1:4,000 at room temperature for 1 h. Detection was performed using enhanced chemiluminescence kit (Pierce, Rockford, IL). Luminescence was evaluated using a Hamamatsu 1394 ORCA-ERA camera, AequoriaMDS Macroscopic Imaging System, and Wasabi software (Hamamatsu Photonics, Herrsching, Germany). Membranes were reprobed with an anti-␤-actin Ab (Santa Cruz). Protein bands were quantified by densitometry, and results were expressed as an MK-to-␤-actin ratio.
Confocal microscopy. Cells were fixed with 3.7% formaldehyde in RPMI medium for 20 min, permeabilized using 0.2% Tween in PBS for 2 min, and subsequently washed and blocked with 1% BSA in PBS. Cells were stained with the polyclonal rabbit anti-MK Ab (Santa Cruz) and the monoclonal anti-58K Golgi protein (Abcam, Cambridge, UK) at 4°C overnight. After being washed three times with PBS, cells were incubated with a secondary Alexa 568-, 546-, or 488-conjugated Ab. Scanning confocal microscopy of cells was conducted with a Zeiss LSM 410/Axiovert 135 microscope using a Zeiss 63ϫ/1.2 water differential interference contrast objective (Zeiss, Göt-tingen, Germany).
Immunoelectron microscopy (pre-embedding technique for transmission electron microscope). Immunolabeling of cells was performed as described previously (35) . Briefly, the cells were treated with hyaluronidase (5,000 units/ml) for 15 min at room temperature. After being washed twice in PBS, the cells were incubated with the primary rabbit anti-MK Ab in a dilution of 1:30 in PBS at 4°C for 10 min. After being washed three times in PBS for 5 min, the cells were stained with the secondary goat anti-rabbit or rabbit anti-goat Ab conjugated with 10 nm gold particles diluted 1:30 in PBS at 4°C for 10 min. The cells were washed and fixed in 1% glutaraldehyde for 10 min at room temperature. This was followed by postfixation in 1% OsO4 for 10 min and rinsing in PBS. Dehydration in ethanol was followed by embedding. Ultrathin sections were contrasted with 2% uranyl acetate and lead citrate. Sections were investigated using a transmission electron microscope (Zeiss EM 10).
ELISA for midkine. The concentration of MK in the supernatant of PMN (5 ϫ 10 6 cells/ml), monocytes (5 ϫ 10 6 cells/ml), and HUVEC (3 ϫ 10 5 cells/ml) cultured under hypoxic conditions was measured in triplicates using the ELISA Development Kit 900-K190 (PeproTech) with a detection limit of 30 pg/ml according to the supplier's instructions.
Chick CAM assay. The CAM assay was performed as described elsewhere (31) . Briefly, fertilized eggs were incubated at 37°C in a humid atmosphere for 10 days. To verify viability of each embryo and to localize blood vessels, eggs were candled. At day 10, a window was opened on the eggshell to expose the CAM. Sterile filter paper discs (28 mm 2 ; catalog number gb002; Whatman, Dassel, Germany) soaked with recombinant human MK, VEGF in PBS at indicated concentrations, or PBS as negative control were carefully placed on top of the CAM in an avascular area. Before growth factors or PBS was applied, filter paper discs were imbued in cortisone acetate (3 mg in 100% ethanol) and dried at room temperature for 30 min. Alternatively, glass coverslips (28 mm 2 ) were coated with growth factors (2 l) at indicated concentrations or PBS as negative control, air dried for 20 min, and placed on the CAM. After 3 days, the CAM was fixed in 3.7% formaldehyde. The CAM was photographed using a Zeiss 200M microscope (Zeiss) at ϫ2.5 magnification. Angiogenic response was quantitatively evaluated by counting the branching points (bifurcations) of the formed vessels per visual field using the UTHSCSA Image Tool (http://ddsdx.uthscsa.edu/dig/download.html; San Antonio, TX).
Ligation of the femoral artery. Animals were housed in cages with a 12-h:12-h day/night cycle. Chow and water were provided ad libitum. All animal procedures were approved and controlled by the local ethics committee and carried out according to the guidelines of the German law for protection of animal life. Male WT and MK Ϫ/Ϫ mice underwent unilateral femoral artery ligation of the right leg for 4 or 7 days as described previously (18) . The left leg was sham operated.
Histology and immunohistochemical analyses. For immunohistochemical analyses, Mm. gastrocnemii were fixed in phosphate-buffered formalin overnight and embedded in paraffin as described previously (8) . Before immunostaining, mounted tissue sections were deparaffinized by rinsing 3 ϫ 5 min in xylene and rehydrated in a graded series of decreasing ethanol concentration. Pretreatment was performed for 2 ϫ 15 min (microwave, 750 W) using target retrieval solution. Subsequently, the slides were rinsed in Tris-buffered saline (pH 7.5). Endogenous peroxidases were quenched in 7.5% H 2O2 in distilled water for 10 min. After a rinse in distilled water for 10 min and with Tris buffer for 2 ϫ 5 min at pH 7.5, the slides were incubated at room temperature for 60 min with the anti-CD31 Ab (dilution, 1:300). After a wash twice for 5 min in Tris buffer, the biotinylated secondary Ab (Vectastain ABC-Kit Elite Goat IgG; Vector, Burlingame, CA) and DABϩ as chromogen were applied. After a rinse with distilled water for 10 min and with TRIS buffer for 2 ϫ 5 min (pH 7.5), sections were incubated with the anti-Ki67 Ab (dilution, 1:20) at room temperature for 1 h. After a wash twice with Tris buffer for 5 min, the APAAP-Rat detection system and Chromogen Red (Dako, Glostrup, Denmark) were used. For BS-1 lectin staining, the slides were pretreated as described above and incubated overnight at 4°C with the biotinylated BS-1 lectin Ab (dilution, 1:200). Immunoreactivity was detected using the Vectastain ABC-Kit Elite and DABϩ according to the manufacturer's instructions. For the evaluation of arteriolar density, slides were incubated with an anti-␣SM-actin Ab (dilution, 1:200) at 4°C overnight. After a wash twice with Tris buffer for 5 min the signal was detected using a biotinylated secondary Ab (Vectastain ABC-Kit Elite Goat IgG; Vector) and DABϩ as chromogen. Thereafter, the slides were rinsed in running water and counterstained with hematoxylin.
Statistical analysis. Data shown represent means Ϯ SD or Ϯ SE, respectively. Statistical significance was determined using Student's t-test or Mann-Whitney Rank Sum test. P Ͻ 0.05 was considered statistically significant.
RESULTS

Hypoxia-induced upregulation of MK protein expression in human PMN.
To identify the potential source of soluble MK in the vascular system during hypoxia in nonmalignant tissue of the adult organism, we studied the expression of MK in different cell systems. Using the Western blotting technique, we detected some basal expression of MK in human PMN freshly isolated from the circulation (Fig. 1A) . After 4 h of hypoxia (1% O 2 ), expression of MK in human PMN was substantially increased compared with the normoxic control at the same time point. Semiquantitative analysis of MK protein expression by calculation of MK protein expression from relative optical densities of MK and ␤-actin protein bands (OD MK /OD ␤-actin ) revealed that the effect was significant (1.1 Ϯ 0.2 vs. 2.7 Ϯ 0.9; n ϭ 4; P Ͻ 0.05). After 6 h of hypoxia, MK expression decreased when compared with the peak value at 4 h of hypoxia, indicating that MK expression was transiently upregulated by hypoxia. Similar to hypoxia, an induction of MK protein expression was observed 4 h after stimulation with 100 nM CoCl 2 (1.4 Ϯ 0.6 vs. 1.9 Ϯ 0.8; n ϭ 4; P Ͻ 0.05), which is known to prevent degradation (4) and inactivation (9, 17) of the HIF-1␣ subunit (Fig. 1B) . Again, 6 h after stimulation by CoCl 2 , MK protein expression was diminished compared with the peak value at 4 h of stimulation. Interestingly, the bacteria-derived tri-peptide fMLP (100 nM), which is known to activate a wide range of PMN functions, was not able to induce MK protein expression at 4 or 6 h of stimulation when compared with unstimulated control at the same time point (Fig. 1C) , indicating that upregulation of MK was specifically induced by hypoxia. To confirm the upregulation of MK by hypoxia, we performed confocal immunofluorescence microscopy. In PMN freshly isolated from the circulation, only some basal MK expression was detectable, whereas 4 h of hypoxia led to markedly increased MK expression when compared with normoxic control at the same time point (Fig. 1D) . However, MK was not detectable in the supernatant of PMN (5 ϫ 10 6 cells/ml) at 4 or 6 h of hypoxia as measured by ELISA technique (data not shown). Here, the MK concentration was below the detection limit of 30 pg/ml, indicating that substantial amounts of soluble MK were not released into the supernatant despite the marked upregulation of its protein expression in PMN during hypoxia. To further characterize the localization of MK during hypoxia, we employed immunoelectron microscopy to study the cell surface expression of MK. We found that MK was almost absent on the surface of human PMN freshly isolated from the circulation. After 4 h of hypoxia, MK was markedly upregulated on the cell surface compared with the normoxic control at this time point (Fig. 2A) . Moreover, MK was identified in cytoplasmatic vesicles (Fig. 2B) . Because only proteins at the cell surface were labeled with the method used, this indicated that MK was internalized before fixation. Taken together, these data suggest that hypoxia-induced MK was not released from PMN but rather presented on and internalized from the cell surface. Thus intact PMN seemed not to represent a source of soluble MK during hypoxia under the experimental conditions used.
Hypoxia induced upregulation of MK expression in human monocytes. Monocytes play an important role in angiogenesis because of their ability to release a variety of proangiogenic factors. Therefore, we studied whether monocytes upregulated MK upon hypoxia by using the Western blot technique. Similar to human PMN, MK protein expression was significantly elevated after 4 h of hypoxia compared with normoxic control (1.2 Ϯ 0.3 vs. 1.9 Ϯ 0.3; n ϭ 4; P Ͻ 0.05). After 20 h of hypoxia, MK expression did not significantly differ from the normoxic control at the same time point (Fig. 3A) . Confocal images of human monocytes confirmed the enhanced MK expression after 4 h of hypoxia compared with normoxic control (Fig. 3B) . In analogy to the immunoelectron microscopy experiments of PMN, we investigated MK cell surface expression of human monocytes. After 4 h of hypoxia, MK expression was increased on the cell membrane of monocytes compared with normoxic conditions. After 20 h of hypoxia, the cell membrane was almost completely covered with MK protein (Fig. 3C) . As seen in human PMN, MK was also identified in endocytotic vesicles indicating internalization of MK from the cell surface (Fig. 3D) . Using ELISA technique, we analyzed the MK concentration in the supernatant of monocytes (5 ϫ 10 6 cells/ml), but MK was not detectable after 0, 4, or 20 h under hypoxic or normoxic conditions (data not shown). Thus monocytes upregulated MK protein expression upon hypoxia, but, similar to PMN, they did not release MK into the supernatant.
Endothelial cells represent a source of soluble MK in the vascular system. We investigated the capability of endothelial cells to express and release MK. After 4 h of hypoxia, MK protein expression was found to be significantly enhanced in HUVEC compared with normoxic control (1.6 Ϯ 0.7 vs. 2.8 Ϯ 0.7; n ϭ 4; P Ͻ 0.05) using the semiquantitative Western blotting technique (Fig. 4A) . No significant difference was observed upon 20 h of hypoxia compared with the normoxic control at the same time point, although MK protein expression was upregulated at this time point when compared with 0 h of culture. Next, we studied MK protein expression in HUVEC using confocal microscopy. As expected, 4 h of hypoxia resulted in elevated MK protein expression compared with the normoxic control (Fig. 4B) . Moreover, MK was localized in perinuclear structures of HUVEC. Costaining of MK and the Golgi apparatus using an antibody against the 58K Golgi protein (58K-GP) revealed that MK was localized in the Golgi apparatus of HUVEC. Next, we studied whether HUVEC can secrete MK and measured MK protein in the supernatant of HUVEC using ELISA technique. In contrast with PMN and monocytes, MK was detected in the supernatant of HUVEC. Here, 4 and 20 h of hypoxia led to significantly increased concentrations of MK in the supernatant of HUVEC compared with normoxic conditions at the same time point (158 Ϯ 45 vs. 301 Ϯ 81 pg/ml and 316 Ϯ 138 vs. 751 Ϯ 272 pg/ml; n ϭ 4; P Ͻ 0.05; Fig. 4C ). . n ϭ 4. B: confocal microscopy images of confluent HUVEC incubated under hypoxia (4 hH) or normoxia (4 h) for control. MK was assessed using the rabbit anti-MK Ab and Alexa 568-conjugated donkey anti-rabbit Ab (red). Indirect fluorescence staining of 58K Golgi protein (58K-GP) was performed using the mouse anti-58K-GP Ab and the secondary Alexa-488 donkey anti-mouse IgG Ab (green). The merged images demonstrate colocalization (yellow). Scale bar ϭ 15 m. n ϭ 3. C: MK concentration in the supernatant of HUVEC as measured by ELISA technique. Means Ϯ SE; n ϭ 4. *P Ͻ 0.05.
MK induced angiogenesis in the CAM assay.
Having identified endothelial cells as a source of soluble MK in the vascular system, we investigated its functional impact on angiogenesis in vivo using the CAM assay. We incubated fertilized eggs at 37°C for 10 days and stimulated angiogenesis by MK, VEGF as positive control, and PBS as negative control. At day 13, the CAMs were microscopically inspected and photographed. Quantitative analysis was performed offline by counting branching points (bifurcations) per visual field in a blinded manner. Images showed an increased number of capillaries after stimulation with MK, demonstrating the ability of MK to induce angiogenesis in vivo. Similarly, an elevated number of branching points was observed after application of VEGF as positive control (Fig. 5A) . Quantitative analysis showed a concentration-dependent significant increase of the number of branching points after stimulation with MK compared with PBS control (211 Ϯ 70 PBS; 564 Ϯ 171, 10 ng/ml MK; 641 Ϯ 162, 30 ng/ml MK; 1,074 Ϯ 54, 100 ng/ml MK; n ϭ 3; P Ͻ 0.05; Fig. 5B ). The number of new blood vessels formed after stimulation with 100 ng/ml MK was even similar in size compared with the effect observed upon application of the same concentration of VEGF (1,074 Ϯ 54 vs. 799 Ϯ 245; n ϭ 3; not significant). Taken together, these data show that soluble MK can serve as a potent proangiogenic factor in vivo.
Angiogenesis was severely compromised in MK-deficient mice. To analyze the relevance of endogenous MK for hypoxiainduced angiogenesis in vivo, we studied MK-deficient mice and WT control animals in a hind limb ischemia model. The right femoral artery of MK-deficient and WT control mice was ligated for 4 or 7 days, and the left femoral artery of each animal was sham operated for internal control. Histological analysis of transverse sections of Mm. gastrocnemii was carried out by staining the endothelial cell marker CD31 and the cell proliferation marker Ki67 (Fig. 6A) . We quantitatively analyzed the histological sections offline by counting CD31/Ki67 double positive cells per visual field in a blinded manner. In WT control mice, we found a significant increase of CD31/Ki67 double positive cells in the ischemic muscle compared with sham-operated controls, indicating endothelial cell proliferation (27 Ϯ 17 vs. 169 Ϯ 34; n ϭ 3; P Ͻ 0.01; Fig. 6B ). This was in sharp contrast with MK-deficient mice, where the number of CD31/Ki67 double positive cells was not increased after ligation of the femoral artery compared with the sham-operated control (72 Ϯ 17 vs. 45 Ϯ 30; n ϭ 4; not significant). To confirm these findings, angiogenesis was studied 7 days after occlusion of the femoral artery (Fig. 6, C and D) . CD31-and BS-1 lectin-positive cells per muscle fiber were counted as an indicator for capillary density. The number of CD31-and BS-1 lectin-positive cells was increased in sections of WT control animals upon femoral artery ligation compared with those of sham-operated mice (CD31, 1.5 Ϯ 0 vs. 5.4 Ϯ 0.4; n ϭ 3; P Ͻ 0.01; BS-1 lectin, 2.1 Ϯ 0.5 vs. 6.5 Ϯ 0.7; n ϭ 3; P Ͻ 0.01; Fig. 6, C and D) . Similar to the results observed after 4 days, sections of MK-deficient mice did not show elevated CD31-or BS-1 lectin-positive cells after femoral artery ligation compared with sham-operated controls (CD31, 1.2 Ϯ 0.2 vs. 1.3 Ϯ 0.1; n ϭ 3; P Ͻ 0.01; BS-1 lectin, 1.9 Ϯ 0.9 vs. 2.0 Ϯ 0.2; n ϭ 3; not significant). In contrast with sections of WT control animals, we observed myofibers with central nuclei in sections of MKdeficient mice 7 days after ligation of the femoral artery, indicating muscle regeneration in the genetic absence of MK (data not shown). Furthermore, arteriolar density was evaluated 7 days after occlusion of the femoral artery. Smooth ␣-actin-positive vessels per visual field were counted. Muscle cross sections of WT and MK-deficient mice showed no difference 7 days after occlusion of the femoral artery (12.4 Ϯ 0.1 vs. 8.3 Ϯ 3.4; n ϭ 3; not significant; data not shown). These findings show that induction of angiogenesis upon ischemia was severely compromised in mice lacking MK expression and suggest a pivotal role of endogenous MK for the induction of angiogenesis in this model.
DISCUSSION
Cells respond to hypoxia by activating a pathway that is regulated by HIF, the key transcriptional regulator of angiogenesis. HIF is a heterodimer consisting of two subunits, the ␣-subunit HIF-1␣, HIF-2␣, or HIF-3␣ and the ␤-subunit HIF-1␤. Whereas HIF-1␤ is constitutively expressed under normoxic conditions, the oxygen degradation domain of HIF-1␣ is hydroxylated by prolyl-4-hydroxylases, leading to its degradation in the proteasome. During hypoxia or administration of "hypoxia mimics" such as CoCl 2 , hydroxylation of the oxygen degradation domain is abrogated and HIF-1␣ can accumulate in the cell (4) . After translocation to the nucleus, HIF-1␣ can bind to a hypoxia response element, which was also found in the MK gene promoter (32) . In our study, we found that hypoxia led to an increased MK protein expression in human PMN, monocytes, and endothelial cells. Similar results were obtained using the HIF-1␣ stabilizing agents CoCl 2 mimicking hypoxia, suggesting the HIF pathway to be involved in MK protein expression of these cell types. However, we cannot rule out that additional mechanisms besides transcriptional regulation may contribute to the increase of MK expression during hypoxia. In contrast with hypoxia, stimulation with the bacteria-derived tri-peptide fMLP, which serves as a potent activator of several functions of PMN such as chemotaxis, reactive oxygen species production, exocytosis, and release of inflammatory mediators, had no effect on MK protein expression in PMN (10) . Thus MK expression may be specifically upregulated in PMN by hypoxia. Although PMN and monocytes showed increased MK expression on their cell surface after stimulation by hypoxia, both cell types did not secrete MK into the supernatant. Taking into consideration that we found MK in endocytotic vesicles of PMN and monocytes, we speculate that MK was rapidly internalized from the surface of these cells by endocytosis. This is in line with findings of other cytokines including the proinflammatory mediator IL-1␤. Human PMN express the two different receptors IL-1RI and IL-1RII. Although IL-1RI is responsible for signal transduction, the predominantly expressed IL-1RII serves as a decoy receptor and exclusively mediates IL-1␤ internalization to interfere with binding of IL-1␤ to IL-1RI. This anti-inflammatory effect is supposed to avoid an excessive inflammatory response (3). However, whether internalization of MK in PMN serves a similar purpose still remains to be determined.
Although MK expression in HUVEC has been described earlier, the influence of hypoxia on MK expression has not been studied so far (37) . In the present study, we were able to show that MK expression was increased under hypoxic conditions in HUVEC. Moreover, MK was found to be localized in the Golgi apparatus of HUVEC and released during hypoxia. Having identified endothelial cells as vascular source of soluble MK, we next demonstrated that soluble MK was able to induce angiogenesis in vivo using the CAM assay. Unexpectedly, the angiogenic response after stimulation with MK was similar compared with the effect observed after application of an equimolar concentration of VEGF. These results are in contradiction to a study published by van der Horst et al. (40) , which showed no angiogenic effect of MK in a CAM assay. These differences may be explained by the high MK concentration (2 g/ml) used in the study by van der Horst and co-workers (40) . We also found that high concentrations of MK (2 g/ml) were unable to induce angiogenesis in vivo (data not shown). Dose-dependent effects are also known for many other proangiogenic cytokines including transforming growth factor-␤ and IL-1 (39) . However, similar to van der Horst et al. (40) we used purified recombinant MK. In earlier studies, the angiogenic potential of MK was only tested using conditioned media of mammalian cancer cell lines overexpressing MK (6), having raised the possibility that the angiogenic effect was not directly mediated by MK. However, we were able to show that direct application of MK induced an angiogenic response in vivo.
One of the most important findings of our study was that angiogenesis was severely compromised in MK-deficient mice after occlusion of the femoral artery in a hind limb ischemia model. In contrast with VEGF knockout mice (5), mice lacking MK were viable and did not show any defects of the vascular system, indicating that MK was dispensable for vasculogenesis of the embryo. This could be explained by the possibility that the absence of MK was either compensated by other angiogenic factors during embryonic development or specifically important for angiogenesis in the adult organism under hypoxia. In the present study, no angiogenic response was observed under hypoxia in the peripheral tissue as measured by proliferation of endothelial cells in a hind limb ischemia model using MK-deficient mice compared with WT animals, which showed a profound angiogenic response. This observation is in line with the finding that the application of exogenous MK under hypoxic conditions induced neovascularization in infarcted rat hearts (11) . In the present study, we delineated the functional impact of endogenous MK for angiogenesis by demonstrating that endogenous MK was indispensable for hypoxia driven angiogenesis in the adult organism. Based on its strong angiogenic potential, our data may define MK as an interesting new candidate for therapeutic intervention in the treatment of ischemic diseases.
